Atria Investments’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Atria Investments’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,321	Closed	-$34.9K	–	2071
2024 Q2	$34.9K	Buy	+15,321	New	+$58.5K	﹤0.01%	1898

Atria Investments's GTHX Position: Q3 2024 in Review

Atria Investments sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 15,321 shares — an estimated $34.9K sold.

Atria Investments first reported a position in GTHX in Q2 2024 and held it in 1 quarter. The position peaked at $34.9K in Q2 2024. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Atria Investments reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Atria Investments sold 15,321 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $34.9K.
Atria Investments first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
Atria Investments's G1 Therapeutics, Inc. Common Stock position peaked at $34.9K in Q2 2024.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Atria Investments's 13F filing for Q3 2024, filed 1 Nov 2024.